Combined Cabozantinib and Nivolumab for Progressive Metastatic Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)
Oncologist 2020 Nov 29;[EPub Ahead of Print], C Kao, DJ George, T ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.